Budesonide Market Forecast 2026–2035: How to Leverage Market Growth

Uncover key drivers, emerging technologies, and competitive movements shaping the budesonide market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Budesonide Market expected to reach by 2030?

The budesonide market has seen significant growth in recent years. Its valuation is set to rise from $10.26 billion in 2025 to $10.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion has been driven by rising asthma and copd prevalence, widespread corticosteroid adoption, expansion of inhalation therapies, increased ibd diagnosis, and improved drug delivery technologies.

The budesonide market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $13.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. Key factors contributing to this growth during the forecast period include an aging global populace, an increase in chronic inflammatory conditions, the broader adoption of generic drugs, the spread of home-based medical treatments, and the escalating burden of respiratory illnesses. Significant trends observed for the forecast duration encompass the increasing application of inhaled corticosteroids in managing chronic respiratory conditions, greater integration into inflammatory bowel disease treatment, a rising demand for specific localized steroid treatments, the proliferation of generic budesonide products, and its expanded role in sustained maintenance therapy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

What Drivers Are Driving Adoption Within The Budesonide Market?

The rising prevalence of respiratory diseases is anticipated to propel the future expansion of the budesonide market. Respiratory diseases are defined as medical conditions impacting the organs and tissues that facilitate gas exchange in animals that breathe air. The surge in these conditions is a result of increasing air pollution, especially exposure to particulate matter and allergens, which significantly contributes to the incidence of asthma and chronic obstructive lung disease. Budesonide is utilized in respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD) to alleviate inflammation, improve airflow, and prevent symptoms such as wheezing and shortness of breath. For example, as reported in August 2025 by the Centers for Disease Control and Prevention, a Switzerland-based public health agency, 90% of the nation’s 4.9 trillion dollars in annual health care spending is allocated to individuals with chronic and mental health conditions. Additionally, more than 84,000 Americans die each year from heart disease or stroke, and the costs associated with cardiovascular diseases are projected to reach roughly 2 trillion dollars by 2050. Therefore, the increasing occurrence of respiratory diseases will drive the growth of the budesonide market.

What Segments Are Included Within The Budesonide Market?

The budesonide market covered in this report is segmented –

1) By Type: Inhalation Powder, Aerosols, Tablets And Capsules

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications

Subsegments:

1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)

2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers

3) By Tablets And Capsules: Oral Tablets, Oral Capsules

What Trends Are Expected To Impact The Competitive Landscape Of The Budesonide Market?

Leading companies within the budesonide market are concentrating on innovations in respiratory treatments, particularly oral therapy, aiming to improve patient convenience, increase treatment adherence, and broaden therapeutic options for managing asthma and other respiratory conditions. Oral therapy budesonide refers to a formulation of budesonide taken by mouth, predominantly utilized in addressing inflammatory conditions. For example, in February 2024, Takeda Pharmaceuticals, a pharmaceutical company based in Japan, announced that the Food and Drug Administration (FDA), a US federal agency, had authorized EOHILIA. This budesonide oral suspension stands as the first and only FDA-approved oral medication for patients aged 11 and above diagnosed with eosinophilic esophagitis (EoE). Moreover, the FDA’s approval for EOHILIA 2 mg twice daily was granted based on efficacy and safety data obtained from two multicenter, randomized, double-blind, parallel-group, placebo-controlled 12-week investigations involving individuals aged 11 to 56 with EoE.

Who Are The Prominent Global Companies Shaping The Budesonide Market Landscape?

Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Budesonide Market?

North America was the largest region in the budesonide market in 2025. The regions covered in the budesonide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Budesonide Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21121&type=smp

Browse Through More Reports Similar to the Global Budesonide Market 2026, By The Business Research Company

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Tea Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/tea-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795